“…Animals dosed with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-exhibited impaired balance and motor coordination, but diminished parkinsonism symptoms and decreased dopaminergic neuronal death when fed a DHA diet (Ozsoy et al, 2011). DHA supplementation may protect dopaminergic neurons in experimental PD models by targeting inflammatory signaling pathways and enhancing the expression of GDNF and Neurturin (member of the same protein family as glial cell-derived neurotrophic factor), which has been shown to benefit the dopaminergic neurons in the substantia nigra which is affected in PD (Bousquet et al, 2011;Cardoso et al, 2012;Hacioglu et al, 2012;Ji et al, 2012;Ozsoy et al, 2011;Tanriover et al, 2010). DHA supplementation in a nonhuman primate MPTP model reduces levodopa-induced dyskinesia, suggesting a safe and innovative therapy for improving the life quality of PD patients (Mahmoudi et al, 2009).…”